The results from this study are consistent with those from others that have evaluated treating melasma using the 4% hydroquinone skin care system in conjunction with other concentrations of tretinoin (0.025%8 or 0.1%9). However, various factors, including differences in inclusion criteria and patient characteristics, preclude meaningful direct comparisons of the results between these studies.